Ruby John Anto
Impact in
- Molecular Medicine top 0.5%
- Curcumin's Biomedical Applications
- Drug Discovery top 1%
Papers in
-
- Curcumin's Biomedical Applications 18
-
- NF-κB Signaling Pathways 5
- Co-authors
- Devarajan Karunagaran (8 shared papers)Smitha Vadakkeveettil Bava (15 shared papers)Arun Kumar T. Thulasidasan (12 shared papers)Ramadasan Kuttan (4 shared papers)Vinod Balachandran (8 shared papers)Srinivas Gopala (2 shared papers)Vineshkumar Thidil Puliyappadamba (7 shared papers)Tessy Thomas Maliekal (3 shared papers)
- Journals
- Journal of Biological Chemistry (5 papers)Frontiers in Oncology (3 papers)Medicinal Chemistry Research (3 papers)Journal of Raman Spectroscopy (3 papers)International Journal of Pharmaceutics (2 papers)
- Partner nations
- IndiaUnited StatesIsrael
In The Last Decade
Ruby John Anto
81 papers receiving 4k citations
Peers
Comparison fields: 5 of 110
- Molecular Medicine 874
- Drug Discovery 30
- Biochemistry 191
- Biomaterials 305
- Cancer Research 309
Countries citing papers authored by Ruby John Anto
This map shows the geographic impact of Ruby John Anto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruby John Anto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruby John Anto more than expected).
Fields of papers citing papers by Ruby John Anto
This network shows the impact of papers produced by Ruby John Anto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruby John Anto. The network helps show where Ruby John Anto may publish in the future.
Co-authors
The 25 scholars most cited alongside Ruby John Anto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 83 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 385 | |
| 2 | 1995 | 271 | |
| 3 | 2002 | 247 | |
| 4 | 2003 | 203 | |
| 5 | 2004 | 199 | |
| 6 | 2003 | 178 | |
| 7 | 2011 | 148 | |
| 8 | 2023 | 134 | |
| 9 | 2014 | 133 | |
| 10 | 2012 | 130 | |
| 11 | 2013 | 121 | |
| 12 | 1996 | 118 | |
| 13 | 2012 | 107 | |
| 14 | 2022 | 105 | |
| 15 | 2010 | 78 | |
| 16 | 2015 | 71 | |
| 17 | 2005 | 69 | |
| 18 | 2014 | 65 | |
| 19 | 1996 | 62 | |
| 20 | 2012 | 61 |
About Ruby John Anto
Ruby John Anto is a scholar working on Molecular Medicine, Cancer Research, Plant Science, Pharmacology and Molecular Biology, having authored 83 papers that have together received 4.1k indexed citations. Recurring topics across this work include Curcumin's Biomedical Applications (18 papers), Medicinal Plant Research (12 papers), Synthesis and biological activity (8 papers), Phytochemical Studies and Bioactivities (7 papers), NF-κB Signaling Pathways (5 papers), Natural product bioactivities and synthesis (5 papers), Bioactive natural compounds (5 papers) and Microbial Natural Products and Biosynthesis (4 papers). The work is most often cited by research in Molecular Medicine (874 citations), Drug Discovery (30 citations), Biochemistry (191 citations), Biomaterials (305 citations) and Cancer Research (309 citations). Ruby John Anto has collaborated with scholars based in India, United States and Israel. Frequent co-authors include Devarajan Karunagaran, Smitha Vadakkeveettil Bava, Arun Kumar T. Thulasidasan, Ramadasan Kuttan, Vinod Balachandran, Srinivas Gopala, Vineshkumar Thidil Puliyappadamba, Tessy Thomas Maliekal, Girija Kuttan and Lekshmi R. Nath. Their work appears in journals such as Journal of Biological Chemistry, Frontiers in Oncology, Medicinal Chemistry Research, Journal of Raman Spectroscopy and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.